Delivery Order SPE2DR25D6028-SPE2DR26FARDB
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Levophed (norepinephrine) in 4-milliliter vials, quantity 10, with a ceiling value of $1,026.68. The contract employs firm fixed price pricing and carries an ultimate completion date of August 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,082.00 to AmerisourceBergen Drug Corp for Levophed SDV 4ML in quantities of 10 units. This non-competed delivery order, issued on October 22, 2025, with completion scheduled for October 23, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency Troop Support Medical awarded a $171.74 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561466511 LEVOPHED 4 MG/4 ML VIAL 4ML. As the parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location between July 11-12, 2023. The delivery order was issued under DLA Troop Support Medical's indefinite-delivery/indefinite-quantity...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Norepinephrine 4 mg/4 ml vials with a ceiling value of $1,107.83. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Norepinephrine 4 mg/4 ml vials. This firm fixed-price delivery order, valued at $3,494.21, is not subject to a set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of May 29, 2025. As a major pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,943.88 on July 29, 2025, for the supply of Norepinephrine 4 mg/4 ml vials. This firm fixed-price contract, which carries an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a $7,210.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Norepinephrine 4 mg/250 ml in dextrose 5% water solution (250 ml units). The contract was competitively awarded without set-aside designation and is scheduled for completion by September 22, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Norepinephrine 8 mg/250 mL in D5W solution with a ceiling value of $1,549.16. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $1,591.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for norepinephrine 4ML 10s, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Levophed (norepinephrine) in 4 milliliter vials, quantity 10, with a ceiling value of $3,567.04 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of November 28, 2025. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor for military and veteran healthcare systems. This delivery order for Levophed—a critical vasopressor medication used in emergency and intensive care settings—reflects the company's role in supplying essential pharmaceuticals to support Department of Defense healthcare operations globally. The firm fixed pricing and rapid fulfillment timeline underscore the operational efficiency required to meet urgent medical supply needs within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/30/25 |